Premium
Diagnostic criteria, severity classification and guidelines of systemic sclerosis
Author(s) -
Asano Yoshihide,
Jinnin Masatoshi,
Kawaguchi Yasushi,
Kuwana Masataka,
Goto Daisuke,
Sato Shinichi,
Takehara Kazuhiko,
Hatano Masaru,
Fujimoto Manabu,
Mugii Naoki,
Ihn Hironobu
Publication year - 2018
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.14162
Subject(s) - guideline , medicine , clinical practice , rheumatology , intensive care medicine , physical therapy , pathology
Several effective drugs have been identified for the treatment of systemic sclerosis ( SS c). However, in advanced cases, not only their effectiveness is reduced but they may be also harmful due to their side‐effects. Therefore, early diagnosis and early treatment is most important for the treatment of SS c. We established diagnostic criteria for SS c in 2003 and early diagnostic criteria for SS c in 2011, for the purpose of developing evaluation of each organ in SS c. Moreover, in November 2013, the American College of Rheumatology and the European Rheumatology Association jointly developed new diagnostic criteria for increasing their sensitivity and specificity, so we revised our diagnostic criteria and severity classification of SS c. Furthermore, we have revised the clinical guideline based on the newest evidence. In particular, the clinical guideline was established by clinical questions based on evidence‐based medicine according to the New Minds Clinical Practice Guideline Creation Manual (version 1.0). We aimed to make the guideline easy to use and reliable based on the newest evidence, and to present guidance as specific as possible for various clinical problems in treatment of SS c.